CDC reported effectiveness of 2-Dose BNT162b2 mRNA vaccine in preventing SARS-CoV-2 infection among children
On Mar. 11, 2022, the BNT162b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine was recommended by CDCﾒs Advisory Committee on Immunization Practices for persons aged 12ﾖ15 years.
Receipt of 2 doses of Pfizer-BioNTech COVID-19 vaccine was shown to be effective in preventing infection with the SARS-CoV-2 B.1.617.2 (Delta) variant in persons aged =12 years.
Tags:
Source: U.S. Centers for Disease Control and Prevention
Credit:
